NAB is happy that language that would have banned advertising new FDA-approved prescription drugs has been removed from a larger bill.
Reps. Edolphus Towns, D-N.Y. and Steve Buyer, R-Ind., sponsored a move to strike the three-year ad ban from FDA legislation. The House Subcommittee on Health passed the amendment by a vote of 23-9.
In a statement, NAB Executive Vice President Dennis Wharton said: “NAB applauds Representatives Towns and Buyer for offering this important pro-consumer amendment. Each year, thousands of Americans seek treatment for heart disease, high blood pressure and other diseases through education that comes in part from prescription drug advertising. There is simply no legitimate reason to deny American citizens this potentially life-saving information.”